Assist. Prof. Dr. Hagar Mohamed Yousef Aly - Medicine and Health Sciences - Best Researcher Award

Liwa College - United Arab Emirates

Author Profile

🎓 Early academic pursuits

Dr. Hagar Mohamed Yousef Aly began her academic journey with a strong foundation in biochemistry and chemistry. she earned her bachelor of science degree in biochemistry/chemistry from alexandria university, egypt. her passion for medical biochemistry led her to pursue a master's degree from the medical research institute at alexandria university, where she deepened her knowledge in the field. driven by a desire to contribute to the scientific community, she further advanced her academic qualifications by obtaining a phd in medical biochemistry/chemistry from the same institute. throughout her academic journey, dr. aly exhibited exceptional dedication and commitment to understanding the intricate mechanisms of biochemistry and molecular biology.

💼 Professional endeavors

Dr. Aly's professional career spans over 15 years of dedicated service in academia across egypt, the kingdom of saudi arabia (ksa), and the united arab emirates (uae). she began her career as a lecturer of chemistry and biochemistry at alexandria university, where she imparted knowledge in various chemistry-related courses including biophysical chemistry, analytical chemistry, organic chemistry, and inorganic chemistry. her exceptional teaching skills and subject-matter expertise allowed her to transition to batterjie medical college in jeddah, ksa, where she served as a lecturer of medicinal chemistry and biochemistry. during her tenure there, she introduced problem-based learning (pbl) methodology in collaboration with maastricht university, holland, providing students with a modern and practical approach to learning. presently, dr. aly holds the position of assistant professor in medical biochemistry/chemistry at liwa college, abu dhabi, uae. she has been instrumental in delivering high-quality education in clinical chemistry, genetics, molecular biology, hematology, and pathophysiology, contributing significantly to shaping the next generation of medical professionals.

🧪 Contributions and research focus

Dr. Aly's research focus is primarily centered around molecular biology, clinical chemistry, and cancer research. her extensive work in the field of gastric cancer has been recognized through Medicine and Health Sciences several high-impact publications. she has contributed immensely to understanding gene profiling in gastric cancer by investigating the expression levels of genes such as sec13, smad7, ghrl, long non-coding rna ghrlos, and hif-1α in gastric cancer patients. her research has paved the way for potential breakthroughs in early diagnosis and treatment of gastric cancer. additionally, dr. aly has explored the role of cannabinoid receptors in chronic hepatitis c virus in obese and non-obese patients, highlighting her diverse research interests. she has also contributed to advancing drug delivery mechanisms using high-frequency ultrasound-assisted techniques combined with hematite iron oxide nanoparticles for lung cancer treatment, showcasing her interdisciplinary research capabilities in nanotechnology and cancer therapeutics.

🏅 Accolades and recognition

Dr. Aly's outstanding contributions to academia and research have earned her notable recognition within the scientific community. she has presented her work at prestigious international Medicine and Health Sciences conferences, including the 45th and 46th international annual conference of the egyptian society of histology and cytology, where her groundbreaking research on liver enzymes and cancer gene profiling was highly appreciated. her recent publication in cancer nanotechnology journal, focusing on sono-photodynamic lung cancer treatment using chia, cress, and flax conjugated hematite iron oxide nanoparticles, has received commendation for its innovative approach to cancer treatment. dr. aly's academic excellence and impactful research have solidified her position as a distinguished figure in the field of medical biochemistry and chemistry.

🌍 Impact and influence

Throughout her career, dr. aly has significantly impacted the academic and scientific communities. her expertise in clinical chemistry and molecular biology has shaped the knowledge and skills of countless medical students, who now contribute to the global healthcare system. her research on gastric cancer, hepatitis c, and cancer therapeutics has influenced further investigations in Medicine and Health Sciences these areas, providing new perspectives for effective treatment options. by integrating problem-based learning (pbl) methodologies in medical education, dr. aly has revolutionized the learning experience for students, fostering critical thinking and practical application of knowledge. her academic influence extends beyond teaching, as she continues to inspire future researchers and medical professionals through her groundbreaking research and innovative approaches.

👣 Legacy and future contributions

Dr. Aly's legacy in the field of medical biochemistry and chemistry is marked by her unwavering dedication to education, research, and innovation. as she continues her academic journey at liwa college, abu dhabi, she remains committed to advancing scientific knowledge and improving healthcare outcomes through her research. her future contributions are poised to bring new insights into cancer therapeutics, gene profiling, and clinical chemistry, further enhancing the understanding and treatment of various medical conditions. dr. aly envisions continuing her role as a mentor, inspiring young researchers and students to explore the fascinating world of biochemistry and medical science. her profound impact on education, research, and healthcare solidifies her status as a visionary leader in the field.

📜 Notable publications

Title: Engineering Solutions in Healthcare: The Government's Role in Decision-Making
Author(s): Mahmoud Khalifa, Sally M. Elsayed, Rashed Alrasheed, Hagar M. Mohamed
Journal: 2024 International Conference on Decision Aid Sciences and Applications (DASA), 2025-01-20
Title: Ethical and Legal Issues of Regenerative Medicine in the UAE
Author(s): Mahmoud Khalifa, Amina Toumi, Hagar M. Mohamed
Journal: 2024 International Conference on Decision Aid Sciences and Applications (DASA), 2025-01-20
Title: Navigating Healthcare Structure: Government Policies and Their Impact on Decisions
Author(s): Mahmoud Khalifa, Samah Anwar, Sally M. Elsayed, Hagar M. Mohamed
Journal: 2024 International Conference on Decision Aid Sciences and Applications (DASA), 2025-01-20
Title: High-frequency ultrasound-assisted drug delivery of chia, cress, and flax conjugated hematite iron oxide nanoparticle for sono-photodynamic lung cancer treatment in vitro and in vivo
Author(s): Abd El-Kaream S.A., Zedan D.F.M., Mohamed H.M., Soliman A.S.M., El-Kholey S.M., Nasra M.K.E.-D.
Journal: Cancer Nanotechnology, 2024
Title: Future Directions: The Role of Government in Shaping Healthcare Engineering Decisions
Author(s): Hagar M. Mohamed, Mahmoud Khalifa
Journal: World Research of Business Administration Journal, 2024-11

EARLY ACADEMIC PURSUITS

Dr. Nathalie Asherie began her academic journey with a Bachelor of Science in Biotechnology Engineering from ORT Braude College in Karmiel, Israel, graduating cum laude in 2000. She then pursued a Master’s degree in Microbiology at the Hebrew University, Hadassah Medical School, Jerusalem, from 2002 to 2005. Her thesis focused on the involvement of the CD44 molecule in Type 1 diabetes of non-obese diabetic (NOD) mice. She continued her education at the same institution, earning a Ph.D. in Immunology, also with honors, and receiving the Excellence Prize for her Ph.D. thesis in 2012. Her doctoral research delved into the role of CD44 in Type 1 diabetes, identifying a redundant molecule, RHAMM, that supports the migration of inflammatory cells, and examining CD44’s role in β-cell demise.

PROFESSIONAL ENDEAVORS

Dr. Asherie's professional career began with a research associate position at Omrix Biopharmaceuticals, where she contributed to the development of life-saving products derived from human plasma. She then interned at Alomone Labs, focusing on polyclonal antibody design and production. Her extensive industry experience provided a solid foundation for her later roles in academia and clinical research.

CONTRIBUTIONS AND RESEARCH FOCUS ON MEDICINE AND HEALTH SCIENCES

Dr. Asherie's research focuses on finding applicative solutions to immune disorders, including autoimmunity, immune deficiency, and cancer. Her significant contributions include the optimization of anti-BCMA CAR-T cells, process development, Medicine and Health Sciences and CAR humanization. Her work on the anti-BCMA CAR-T based treatment for MM and AL is particularly noteworthy, having enrolled and treated nearly 80 patients. Her innovative research has been published extensively, highlighting her role in advancing cellular therapies and immunological treatments.

IMPACT AND INFLUENCE

Dr. Asherie’s impact is evident in her numerous publications and the successful clinical trials she has led. Her work has garnered recognition in the scientific community, evidenced by awards such as the First Best Abstract Award at the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies in 2022 and the Excellence Prize for her Ph.D. thesis. Her contributions to the field of immunology and cellular therapy have influenced current practices and opened new avenues for treatment.

ACADEMIC CITES

Dr. Asherie’s research has been widely cited in the scientific literature, reflecting her influence in the field. Key publications include her work on the anti-BCMA CAR-T cells published in Haematologica and the Journal of Clinical Oncology, Medicine and Health Sciences which have contributed significantly to the understanding and treatment of multiple myeloma and other immune-related disorders. Her research on the molecular mechanisms involving miR-103 in glucocorticoid-induced apoptosis of hemopoietic tumor cells has also been influential.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Asherie’s legacy is marked by her pioneering research and successful implementation of advanced cellular therapies. Her work on CAR-T cell therapy for cancer treatment represents a significant advancement in the field. Moving forward, she aims to continue her research in immunology, focusing on developing novel treatments for immune disorders and enhancing the efficacy of existing therapies. Her commitment to training new personnel and her ongoing contributions to clinical trials ensure that her impact will extend well into the future.